Skip to content
★ Sign in to follow
JM

James M. Hussey

CEO
Sagent Pharmaceuticals, Inc.
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 27 Feb 2015 for Sagent Pharmaceuticals, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

James M. Hussey: trading record in brief

All filings by James M. Hussey on record concern Sagent Pharmaceuticals, Inc. The record holds 3 filings, for trades running from 18 February 2014 to 25 February 2015.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 27 February 2015, reports a share grant in Sagent Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to James M. Hussey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total

3 of 3 declarations